Bio-Rad Laboratories (BIO-B) Net Margin (2009 - 2026)
Bio-Rad Laboratories (BIO-B) reported Net Margin of 89.02% for Q1 2026, down 9995.0% year-over-year from N/an in Q1 2025, and down 185.71% on a QoQ basis from 103.87% in Q4 2025.
Bio-Rad Laboratories (BIO-B) has 18 years of Net Margin data on file, last reported at 89.02% in Q1 2026.
- Quarterly Net Margin fell 9995.0% year-over-year to 89.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6.52% (up 9168.0% YoY) and the FY2025 annual result came in at 29.42%, up 10127.0% from the prior year.
- Net Margin retreated to 89.02% in Q1 2026 per BIO-B's latest filing, from 103.87% in the prior quarter.
- Across five years, Net Margin topped out at 113.35% in Q4 2022 and bottomed at 480.98% in Q1 2022.
- The 5-year median for Net Margin is 10.19% (2023), against an average of 51.68%.
- The widest annual swing landed in 2022, when Net Margin tumbled 61546 bps; it then surged 49117 bps in 2023.
- Tracing BIO-B's Net Margin over 5 years: stood at 113.35% in 2022, then plunged by 55 bps to 51.34% in 2023, then tumbled by 309 bps to 107.24% in 2024, then surged by 197 bps to 103.87% in 2025, then slumped by 186 bps to 89.02% in 2026.
- Per Business Quant, the three latest BIO-B Net Margin figures stand at 89.02% (Q1 2026), 103.87% (Q4 2025), and 52.36% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | -89.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.02% |
| Dec 31, 2025 | 103.87% |
| Sep 30, 2025 | -52.36% |
| Jun 30, 2025 | 48.77% |
| Mar 31, 2025 | 10.93% |
| Dec 31, 2024 | -107.24% |
| Sep 30, 2024 | 100.54% |
| Jun 30, 2024 | -339.15% |
| Mar 31, 2024 | 62.85% |
| Dec 31, 2023 | 51.34% |
| Sep 30, 2023 | 16.81% |
| Jun 30, 2023 | -170.64% |
| Mar 31, 2023 | 10.19% |
| Dec 31, 2022 | 113.35% |
| Sep 30, 2022 | -23.91% |
| Jun 30, 2022 | -133.86% |
| Mar 31, 2022 | -480.98% |
| Dec 31, 2021 | -213.61% |
| Sep 30, 2021 | 525.84% |
| Jun 30, 2021 | 127.69% |
| Mar 31, 2021 | 134.48% |
| Dec 31, 2020 | 107.25% |
| Sep 30, 2020 | 203.12% |
| Jun 30, 2020 | 180.00% |
| Mar 31, 2020 | 120.00% |
| Dec 31, 2019 | 88.62% |
| Sep 30, 2019 | -46.17% |
| Jun 30, 2019 | 104.58% |
| Mar 31, 2019 | 156.17% |
| Dec 31, 2018 | -134.30% |
| Sep 30, 2018 | 49.40% |
| Jun 30, 2018 | 46.54% |
| Mar 31, 2018 | 119.09% |
| Dec 31, 2017 | 13.31% |
| Sep 30, 2017 | 4.13% |
| Jun 30, 2017 | 1.00% |
| Mar 31, 2017 | 2.47% |
| Dec 31, 2016 | -3.26% |
| Sep 30, 2016 | 3.36% |
| Jun 30, 2016 | 3.21% |
| Mar 31, 2016 | 2.33% |
| Dec 31, 2015 | 8.00% |
| Sep 30, 2015 | 3.70% |
| Jun 30, 2015 | 5.62% |
| Mar 31, 2015 | 3.77% |
| Dec 31, 2014 | 6.53% |
| Sep 30, 2014 | 2.17% |
| Jun 30, 2014 | 5.89% |
| Mar 31, 2014 | 1.31% |
| Dec 31, 2013 | 5.00% |
| Sep 30, 2013 | -1.41% |
| Jun 30, 2013 | 6.59% |
| Mar 31, 2013 | 4.04% |
| Sep 30, 2012 | 8.43% |
| Jun 30, 2012 | 9.40% |
| Mar 31, 2012 | 6.28% |
| Dec 31, 2011 | 10.82% |
| Sep 30, 2011 | 8.78% |
| Jun 30, 2011 | 7.66% |
| Mar 31, 2011 | 6.54% |
| Dec 31, 2010 | 12.01% |
| Sep 30, 2010 | 8.65% |
| Jun 30, 2010 | 4.47% |
| Mar 31, 2010 | 7.79% |
| Dec 31, 2009 | 3.84% |
| Sep 30, 2009 | 8.52% |
| Jun 30, 2009 | 13.87% |